Jean-pierre P. Bourquin
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemia.
Journal: Science advances
Published: May 06, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.
Journal: Leukemia
Published: April 03, 2026
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation.
Journal: Clinical pharmacokinetics
Published: February 05, 2026
Systematic review of hematopoietic stem cell transplantation in patients with ataxia telangiectasia: a case report and an individual patient-level analysis.
Journal: Frontiers in immunology
Published: November 25, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 10, 2025
Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort study.
Journal: The Lancet regional health. Southeast Asia
Published: September 12, 2025
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy.
Journal: HemaSphere
Published: May 27, 2025
Last Updated: 09/26/2026